NARDON, CHIARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.763
EU - Europa 460
AS - Asia 242
AF - Africa 5
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 1
Totale 3.475
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.757
CN - Cina 214
IT - Italia 122
UA - Ucraina 80
FI - Finlandia 76
SE - Svezia 74
GB - Regno Unito 43
DE - Germania 32
IN - India 18
IE - Irlanda 16
FR - Francia 8
CA - Canada 5
VN - Vietnam 5
IR - Iran 4
BE - Belgio 3
EG - Egitto 3
EU - Europa 3
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AU - Australia 1
GR - Grecia 1
HK - Hong Kong 1
LT - Lituania 1
MD - Moldavia 1
PL - Polonia 1
PR - Porto Rico 1
RO - Romania 1
RU - Federazione Russa 1
Totale 3.475
Salva come PNG Salva come JPEG
Città #
Ann Arbor 441
Fairfield 409
Woodbridge 273
Chandler 201
Houston 168
Seattle 158
Wilmington 158
Ashburn 153
Cambridge 145
Padova 69
Jacksonville 66
Beijing 59
Princeton 54
Medford 50
San Diego 42
Nanjing 37
Boardman 34
Des Moines 31
Helsinki 28
New York 20
Roxbury 15
Shenyang 13
Dublin 12
Guangzhou 12
Hebei 11
Hefei 11
Nanchang 11
Jiaxing 10
Jinan 9
London 8
Cagliari 6
Redwood City 6
Shanghai 6
Dong Ket 5
Phoenix 5
Changsha 4
Indiana 4
Kunming 4
Norwich 4
Ogden 4
Taizhou 4
Toronto 4
Andover 3
Borås 3
Detroit 3
Falls Church 3
Galway 3
Meybod 3
Norwalk 3
Chengdu 2
Fuzhou 2
Haikou 2
Hounslow 2
Islington 2
Kharkiv 2
Kilburn 2
Lappeenranta 2
McAllen 2
Milan 2
Ospedaletto Euganeo 2
Prescot 2
Taiyuan 2
Tappahannock 2
Treviso 2
Xian 2
Zhengzhou 2
Acerra 1
Albano Sant'alessandro 1
Albignasego 1
Alexandria 1
Athens 1
Boston 1
Brescia 1
Brussels 1
Carrara 1
Chisinau 1
Dearborn 1
Derby 1
El Segundo 1
Falkenstein 1
Florence 1
Grand Rapids 1
Hangzhou 1
Herstal 1
Kashan 1
Marche 1
New Bedfont 1
Nuremberg 1
Palermo 1
Porto Torres 1
Quanzhou 1
Raleigh 1
Redmond 1
Reggio Emilia 1
Rome 1
Sambuceto 1
San Antonio 1
Smyrna 1
Swansea 1
Sydney 1
Totale 2.853
Salva come PNG Salva come JPEG
Nome #
Synthesis, chemical characterization and cancer cell growth-inhibitory activities of Cu(ii) and Ru(iii) aliphatic and aromatic dithiocarbamato complexes 156
CuII and AuIII Complexes with Glycoconjugated Dithiocarbamato Ligands for Potential Applications in Targeted Chemotherapy. 149
New comprehensive studies of a gold(III) Dithiocarbamate complex with proven anticancer properties: Aqueous dissolution with cyclodextrins, pharmacokinetics and upstream inhibition of the ubiquitin-proteasome pathway 132
Targeting the ubiquitin-proteasome pathway with inorganic compounds to fight cancer: a challenge for the future. 119
Cell and cell-free mechanistic studies on two gold(III) complexes with proved antitumor properties 111
Promising Anticancer Mono- and Dinuclear Ruthenium(III) Dithiocarbamato Complexes: Systematic Solution Studies 110
Ru(III) anticancer agents with aromatic and non-aromatic dithiocarbamates as ligands: Loading into nanocarriers and preliminary biological studies 106
Gold complexes for therapeutic purposes: An updated Patent review (2010-2015) 106
Cellular and Computational Studies of Proteasome Inhibition and Apoptosis Induction in Human Cancer Cells by Amino Acid Schiff Base-Copper Complexes 99
COMPOSTI DI COORDINAZIONE, SINTESI, NANOFORMULAZIONE ED USO DEGLI STESSI IN ONCOLOGIA (Au, Cu) 96
Gold(III)-Dithiocarbamato Peptidomimetics in the Forefront of the Targeted Anticancer Therapy: Preclinical Studies against Human Breast Neoplasia 95
Gold(III) complexes sensitize mitochondria of tumor cells to permeability transition. 93
Is matching ruthenium with dithiocarbamato ligands a potent chemotherapeutic weapon in oncology? 91
Gold(III) Complexes in the Oncological Preclinical Arena: from Aminoderivatives to Peptidomimetics 90
COMPOSTI DI COORDINAZIONE, SINTESI, NANOFORMULAZIONE ED USO DEGLI STESSI IN ONCOLOGIA (Ru, Ga) 89
Gold(III)-pyrrolidinedithiocarbamato Derivatives as Antineoplastic Agents 83
Toward the selective delivery of chemotherapeutics into tumor cells by targeting peptide transporters: tailored gold-based anticancer peptidomimetics 83
Anticancer Gold(III) Peptidomimetics: From Synthesis to in vitro and ex vivo Biological Evaluations 82
Noble metal-dithiocarbamates: precious allies in the fight against cancer 80
Au(III)-Proline derivatives exhibiting selective antiproliferative activity against HepG2/SB3 apoptosis-resistant cancer cells 80
Gold-based peptidomimetics for a targeted anticancer therapy 70
Anti-cancer chemotherapeutics in target therapy: from advanced preclinical studies on promising Au(III) peptidomimetics toward the design of new receptor-recognizable metal-based agents 64
Preclinical activity of multiple-target gold(III)-dithiocarbamato peptidomimetics in prostate cancer cells and xenografts 63
Beyond Platinums: Gold Complexes as Anticancer Agents 62
Perspective gold(III)-dithiocarbamato anticancer therapeutics: learning from the past, moving to the future. 61
CCK8 peptide-labeled Pluronic® F127 micelles as a targeted vehicle of gold-based anticancer chemotherapeutics 60
Gold(III) dithiocarbamate complexes induce cell death triggered by thioredoxin redox system inhibition, mitochondrial permeability increase, and activation of ERK pathway 56
New lanthanide-based biosensors for the early detection of cancer antigens 55
Target selective micelles for bombesin receptors incorporating Au(III)-dithiocarbamato complexes 55
Design and development of new metal-based biosensors for the early detection of cancer antigens in oncology 50
null 50
Studio pilota sull’efficacia di una formulazione micellare contenente un complesso di Au(III) nel trattamento dell’artrite sperimentale da collagene nel topo 48
An excellence in medicinal inorganic chemistry: a portrait of the gold(I/III) complexes patented for therapeutic purposes from 2010 to 2015 48
Labelled micelles for the delivery of cytotoxic Cu(II) and Ru(III) compounds in the treatment of aggressive orphan cancers: design and biological in vitro data 48
Metal-based dithiocarbamato anticancer agents: an overview 47
Copper(II)- and Ruthenium(III)-based complexes with promising anticancer activity 44
Ubiquitin-Proteasome System impairment by the Gold(III) complex derivative AuL12 43
Cutting-Edge Nanosystems for Biomedical Applications 43
New metal-based cancer-targeting chemotherapeutics 43
CCK8 receptor-mediated cancer treatment strategies in target therapy 42
DESIGN AND DEVELOPMENT OF NEW METAL-BASED BIOSENSORS FOR THE EARLY DETECTION OF CANCER ANTIGENS IN ONCOLOGY 38
20S proteasome inhibition by gold(III)-based antitumor agents: from in vitro and in vivo studies to X-ray crystallography 38
null 37
Selective delivery of chemotherapeutics into tumor cells by use of targeting peptides 37
From cisplatin to world-shattering gold(III) anticancer agents 30
Throwing light on recent advances on metallodrugs: From deemed poisons to a striking hope for the future 28
Cutting-edge anticancer agents: gold-based peptidomimetics targeting peptide transporters 26
Novel inorganic chemotherapeutics for cancer treatment 25
“Composti di coordinazione, sintesi, nanoformulazione ed uso degli stessi come antinfiammatori” 25
Design and Development of new metal-based biosensors for the early detection of cancer antigens in oncology 22
Leading-edge gold(III) targeted chemotherapeutics in translational oncology 22
Composti di coordinazione, sintesi, nanoformulazione ed uso degli stessi come antinfiammatori” n° domanda:102016000122377, brevetto per invenzione industriale (antiflogistic), 20
New insights into the mechanism of action of the gold(III) dithiocarbamato complex AuL12: upstream inhibition of the ubiquitin-proteasome pathway and encapsulation in natural polysaccharides 19
A new strategy in chemotherapy: preliminary studies on Cu(II) complexes aimed at exploiting the enhanced copper uptake in malignancies 18
Biological studies on Au(III) peptidomimetics about to enter Phase I clinical trials 15
Gold(III)- to Ruthenium(III)-metal exchange in dithiocarbmato complexes tunes their biological mode of action for cytotoxicity in cancer cells 15
null 13
In vitro and in vivo anticancer activity of recently patented gold-based peptidomimetics targeting peptide transporters 10
New metal-based cancer-targeting chemotherapeutics 9
Totale 3.549
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.010
article - articoli 7.363
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 486
selected - selezionate 0
volume - volumi 230
Totale 19.089
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019163 0 0 0 0 0 0 0 0 0 0 90 73
2019/2020666 102 27 2 32 58 44 92 82 62 72 65 28
2020/2021595 27 36 27 31 34 50 24 40 56 141 88 41
2021/2022633 36 113 63 63 33 29 30 60 24 21 42 119
2022/2023474 92 7 3 46 126 60 3 40 72 1 21 3
2023/2024204 21 44 29 21 18 27 7 8 8 21 0 0
Totale 3.549